Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpoint

Abstract

MRSA with ceftaroline MICs of 1 and 2 mg/L were poorly discriminated by routine methods. Solutions lie in greater standardization, automation or dosages justifying a higher breakpoint.